Weighted mixed-comparator cost

Calculates expected comparator cost as the treatment-share-weighted mean cost of the current-care options.

Signature

C_mix = sum_(j=1)^J (w_j * C_j)
Inputs
InputsDefinitionUnit
w_jProportion of the comparator population receiving current-care option jproportion
C_jExpected relevant cost of current-care option jcurrency per defined population or person
Output
C_mixTreatment-share-weighted expected cost of the mixed comparatorcurrency per defined population or person
  • J Number of mutually exclusive current-care options represented in the mixed comparator (count)

Function

Mixed-comparator construction function

Maps the treatment shares and expected results of current-care options to a weighted mixed comparator.

Try this function

Implementations

  • Excel

    Calculate weighted comparator cost

    Excel multiplies each option cost by its treatment share and adds the products.

    =SUMPRODUCT(TreatmentShares,OptionCosts)

Assumptions

  • Valid treatment shares

    Treatment shares are non-negative and sum to 1 across the mutually exclusive comparator options.

  • Representative current practice

    Treatment shares reflect the expected comparator mix for the relevant population, setting and period.

  • Consistent costing basis for mixed comparator

    Option costs use the same perspective, population, time horizon, currency and price year.

Worked examples

  • Weighted comparator cost

    Current care consists of Option A for 70% of patients at £10,000 each and Option B for 30% at £15,000 each. Mixed-comparator cost is £11,500 per patient.

    J = 2; w_j = [0.70,0.30]; C_j = [10000,15000]; C_mix = 11500

Common errors

  • Using outdated treatment shares

    A mixed comparator based on historical or irrelevant treatment shares may not represent the decision-maker's expected current practice.

Sources

  • NICE manual on comparators from established practice

    National Institute for Health and Care Excellence. NICE technology appraisal and highly specialised technologies guidance: the manual (PMG36). Published 31 January 2022, last updated 13 October 2026. Sections 2.2.12 to 2.2.13 (The scope: comparators) and 6.2.2 to 6.2.3 (Committee recommendations: comparators).

    View source →

  • ISPOR report on costing a treatment mix

    Sullivan SD, Mauskopf JA, Augustovski F, Jaime Caro J, Lee KM, Minchin M, et al. Budget impact analysis: principles of good practice. Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value in Health. 2014;17(1):5-14.

    View source →

Canonical Identity

Stable URI · Machine-readable · Resolvable · CC BY 4.0